Maxilon was founded in 1995 to create, manufacture and market innovative surgical instruments through the use of high technology materials and methods.
Peter R. Ebner, a high-tech inventor and entrepreneur, is the owner and CEO. He is a former MIT fellow of the Center for Advanced Engineering Studies and has extensive product design and manufacturing experience utilizing a wide range of technologies. He has created many new products and has been granted over sixty patents world-wide. Ebner also brings business experience to Maxilon, including the founding of high-tech companies, and having served on a NASDAQ listed company board of directors.
The mx-grafter bone grafting system was Maxilon's first product. A local oral surgeon presented the need and assisted Ebner during the design of the instrument. The design objective was to create a bone grafting device capable of performing all of the essential grafting steps with a single instrument. The resulting disposable product rapidly harvests, collects and delivers bone in an efficient process, greatly simplifying autogenous bone grafting procedures.
During use of the grafter it was observed that thin convoluted shavings were being formed and that they were saturated with blood. A patent was issued which covered the unique morphology and other properties of this osseous coagulum; now known as XBR or Expanded Bone Regeneration.
In the early days, it had been reported that very good results were being obtained with the mx-grafter. This lead to increasing interest in the biology and the initiation of an extensive clinical study involving 193 consecutive patients. The results confirmed that yes, excellent clinical results were being obtained with a very high rate of successful outcomes.